Interviews /
by Peter Milios -
9 months ago
14 Mar 2024 - Delve into the cutting-edge realm of regenerative medicine with Kilian Kelly, CEO of Cynata Therapeutics. Learn how their stem cell innovations are shaping the future…
Interviews /
by Rachael Jones -
4 years ago
31 Mar 2020 - Cynata Therapeutics Limited (ASX:CYP) Managing Director, Dr Ross MacDonald, talks 1H20 results, upcoming Phase 2 clinical trials, licensing and strategy to build the …
Company Presentations /
by -
4 years ago
31 Mar 2020 - Cynata Therapeutics Limited (ASX:CYP) Managing Director Dr Ross MacDonald presents on 1H20 results, upcoming Phase 2 clinical trials, licensing and strategy to build …
Market Reports /
by Ortenzia Borre -
4 years ago
14 Jan 2020 - It’s been a positive day of trade for the Australian share market closing 0.9 per cent higher. Kangaroo Island Plantation Timbers (ASX:KPT) report further damage.
Company News /
by Anna Napoli -
4 years ago
14 Jan 2020 - Cell therapeutics company Cyanata (ASX:CYP) has received the greenlight from British medical authority MHRA to begin the company’s Phase 2 clinical trial of its CYP-0…
Company News /
by Rachael Jones -
4 years ago
07 Jan 2020 - Biotechnology company Cynata Therapeutics (ASX:CYP) has received an almost $2 million R&D Tax Incentive Refund for the 2018/2019 financial year.
Market Reports /
by Rachael Jones -
5 years ago
25 Nov 2019 - The ASX rose at the open and is now tracking 0.6% higher at noon. The Afterpay Touch Group (ASX:APT) shares shot up on the back of its final audit provided to AUSTRAC…
Market Reports /
by Rachael Jones -
5 years ago
17 Oct 2019 - The ASX dropped at the open and failed to gain momentum closing 0.8% lower. Shares in Wisetech Global (ASX:WTC) slumped today - they have entered into a trading halt …
Company News /
by Rachael Jones -
5 years ago
17 Oct 2019 - Biotech company Cynata Therapeutics (ASX:CYP) has decided to withdraw from acquisition discussions with Sumitomo Dainippon Pharma Co.
Company News /
by Rachael Jones -
5 years ago
04 Sep 2019 - Clinical-stage biotechnology company Cynata Therapeutics (ASX:CYP) is excited to have a scientific paper published on the efficacy of Cymerus MSCs in a preclinical mo…
Company News /
by Anna Napoli -
5 years ago
07 Jan 2019 - Cynata Therapeutics (ASX:CYP) has received the green light from IP Australia for its Cymerus technology.
Company Presentations /
by -
7 years ago
27 Oct 2016 - Cynata Therapeutics Limited (ASX:CYP) Managing Director and CEO Dr Ross Macdonald provides an overview of the company's stem cell manufacturing platform, commercialis…
Interviews /
by Jessica Amir -
7 years ago
26 Oct 2017 - Cynata Therapeutics Limited (ASX:CYP) Managing Director & CEO, Dr. Ross Macdonald provides an update on its Phase 1 clinical trial for the treatment of Graft versus H…
Company News /
by Jessica Amir -
7 years ago
27 Jun 2017 - Cynata Therapeutics (ASX:CYP) has announced it commenced patient dosing in the first ever clinical trial of stem cell therapy for graft-versus host disease therapy.
Interviews /
by -
9 years ago
28 Apr 2015 - Cynata Therapeutics Limited (ASX:CYP) Managing Director and CEO Ross Macdonald details plans to commercialise its therapeutic technology.
Stock Watch /
by -
9 years ago
25 Feb 2015 - Investment advisor Gary Glover takes a technical look at S&P/ASX200, NASDAQ, LEI, DOW, PBG, HZN, CYP
Market Reports /
by -
10 years ago
18 Sep 2014 - Aus shares reverse early gains. Shares in Arrium Limited (ASX:ARI) slumped more than 25 per cent as it completes the institutional component of a $754M capital raisin…
